Llwytho...
Direct‐acting antiviral therapy for chronic hepatitis C virus genotype 4 infection: Exploring new regimens
The optimal antiviral regimen for hepatitis C virus (HCV) genotype 4 is still a subject of investigation. The report in this issue of Health Science Reports by Asselah and colleagues investigated the additional benefit of extending treatment duration of the ombitasvir/paritaprevir/ritonavir plus rib...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Health Sci Rep |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6427055/ https://ncbi.nlm.nih.gov/pubmed/30937390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hsr2.106 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|